Skip to main content
TWST
NASDAQ Life Sciences

Officer Dennis Cho Files Intent to Sell Nearly $1 Million in Stock Near 52-Week Highs

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$69.22
Mkt Cap
$4.31B
52W Low
$23.3
52W High
$71.04
52W Position info
197% above low
Off High info
2.6% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

TWST has more than doubled off its 52-week low of $23.3.

Summary

Officer Dennis Cho plans to sell nearly $1 million in Twist Bioscience stock, adding to recent insider selling activity as the stock approaches its 52-week high.


Key Events · Ownership and Investor Activity · TWST

  • Officer Files Intent to Sell Stock

    Dennis Cho, an officer, has filed a Form 144 indicating an intent to sell 14,205 shares of common stock, valued at approximately $990,798.75.

  • Sale Near 52-Week High

    The proposed sale comes as Twist Bioscience stock is trading near its 52-week high of $71.04, potentially indicating profit-taking by the insider.

  • Continuation of Insider Selling Trend

    This filing contributes to a broader trend of insider selling at the company, with over $6.2 million in open-market sales by insiders in the last 90 days, including two other significant Form 144 filings this week.


Analysis · TWST · Life Sciences

An officer of Twist Bioscience, Dennis Cho, has filed a Form 144 indicating an intent to sell approximately $990,798 worth of company stock. This proposed sale, occurring while the stock trades near its 52-week high, suggests the officer is taking profits or managing personal liquidity. This follows a pattern of insider selling observed over the past 90 days, totaling over $6.2 million.

How filings like this one have moved

In the 30 days to Sep 16, 2026, 29.6% of the 1725 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TWST was trading at $69.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $23.30 to $71.04. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TWST - Latest Insights

TWST
Sep 16, 2026, 10:59 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $144.43
Real-time Price: $141.46 info
Change: -$2.97 (-2%) info
Market Cap: $9.312B info
TWST
Aug 19, 2026, 4:11 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $140.00
Real-time Price: $141.46 info
Change: +$1.46 (+1%) info
Market Cap: $9.312B info
TWST
Aug 19, 2026, 12:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $136.04
Real-time Price: $141.46 info
Change: +$5.41 (+4%) info
Market Cap: $9.312B info
TWST
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $118.00
Real-time Price: $141.46 info
Change: +$23.46 (+20%) info
Market Cap: $9.312B info
TWST
Aug 05, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $141.46 info
Change: +$26.46 (+23%) info
Market Cap: $9.312B info